KRUTI PATEL-KONASAGAR: Open Payments
NPI 1932714722 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,138 in 182 payments from 32 companies in 2025. Trend: 2023 $2,675 · 2024 $3,256 · 2025 $4,138
Food & beverage: $4,138
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation | 20 | $598 |
| Novo Nordisk Inc | 25 | $432 |
| Corcept Therapeutics | 17 | $331 |
| CeQur Corporation | 1 | $286 |
| Dexcom, Inc. | 25 | $273 |
| Tandem Diabetes Care, Inc. | 6 | $245 |
| Lilly USA, LLC | 10 | $241 |
| Ascendis Pharma Endocrinology Inc | 5 | $224 |
| Amgen Inc. | 15 | $215 |
| Sequel Med Tech, LLC | 5 | $194 |
Products named: AFREZZA, Korlym, CeQur Simplicity, Dexcom G6 Transmitter, Ozempic, t:slim X2 Insulin Pump with Control-IQ, Yorvipath, TWIIST.
Industry payments across TX — which companies pay providers there.
